scispace - formally typeset
P

Paolo Morazzoni

Researcher at Roswell Park Cancer Institute

Publications -  148
Citations -  5498

Paolo Morazzoni is an academic researcher from Roswell Park Cancer Institute. The author has contributed to research in topics: Salvia miltiorrhiza & Hyperforin. The author has an hindex of 41, co-authored 147 publications receiving 5094 citations. Previous affiliations of Paolo Morazzoni include Mario Negri Institute for Pharmacological Research.

Papers
More filters
Journal ArticleDOI

Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine

TL;DR: The results suggest that curcumin formulated with phosphatidylcholine furnishes higher systemic levels of parent agent than unformulatedCurcumin.
Journal ArticleDOI

Clinical effects of a standardized soy extract in postmenopausal women: a pilot study.

TL;DR: SOYSELECT may be a safe and efficacious therapy for relief of hot flushes in women who refuse or have contraindications for hormone replacement therapy.
Journal ArticleDOI

Cancer prevention in Europe: the Mediterranean diet as a protective choice.

TL;DR: The biological mechanisms for cancer prevention associated with the Mediterranean diet have been related to the favourable effect of a balanced ratio of omega 6 and omega 3 essential fatty acids and high amounts of fibre, antioxidants and polyphenols found in fruit, vegetables, olive oil and wine.
Journal Article

Free radicals scavenging action and anti-enzyme activities of procyanidines from Vitis vinifera. A mechanism for their capillary protective action.

TL;DR: The results of the second part of this study show that procyanidines, in addition to free radical scavenging action, strongly and non-competitively, inhibit xanthine oxidase activity, the enzyme which triggers the oxy radical cascade.
Journal ArticleDOI

The α′ Subunit from Soybean 7S Globulin Lowers Plasma Lipids and Upregulates Liver β-VLDL Receptors in Rats Fed a Hypercholesterolemic Diet

TL;DR: The results represent the first in vivo evidence of both the plasma lipid-lowering properties and the upregulation of liver beta-VLDL receptors induced by the soybean alpha' subunit.